Uncategorized – Page 7 – Policy & Medicine

Mylan CEO Under Fire at House Hearing

PDUFA IV: Full Steam Ahead?

On a Collision Course – FDA Clinical Investigator Disclosure and Open Payments

Webinar – Next Generation Compliance: Using Analytics to Reduce Compliance Risk

Mylan Pricing Summary: A Case Study in Increases

ABIM and ACCME Expand Collaboration

The National MACRA MIPS/APM Summit

Surgeon General Sends Out Letter on Opioids

Seventeenth Annual Pharmaceutical and Medical Device Compliance Congress

New Study on Physician-Industry Relationships, This Time Focused on Ophthalmologists